Vanishing Bile Ducts in the Long Term after Pediatric Hematopoietic Stem Cell Transplantation

Chow, 2016, Late effects surveillance recommendations among survivors of childhood hematopoietic cell transplantation: a Children's Oncology Group Report, Biol Blood Marrow Transplant, 22, 782, 10.1016/j.bbmt.2016.01.023 McDonald, 2016, How I treat acute graft-versus-host disease of the gastrointestinal tract and the liver, Blood, 127, 1544, 10.1182/blood-2015-10-612747 Norvell, 2015, Liver disease after hematopoietic cell transplantation in adults, Transplant Rev, 29, 8, 10.1016/j.trre.2014.08.001 Hoffer, 2000, Liver biopsy methods for pediatric oncology patients, Pediatr Radiol, 30, 481, 10.1007/s002470000244 Oshrine, 2011, Safety and utility of liver biopsy after pediatric hematopoietic stem cell transplantation, J Pediatr Hematol Oncol, 33, e92, 10.1097/MPH.0b013e3182025236 Matsukuma, 2016, Diagnosis and differential diagnosis of hepatic graft versus host disease (GVHD), J Gastrointest Oncol, 7, S21 Tomás, 2000, Long-term liver dysfunction after allogeneic bone marrow transplantation: clinical features and course in 61 patients, Bone Marrow Transplant, 26, 649, 10.1038/sj.bmt.1702532 Arai, 2016, Risk factors and prognosis of hepatic acute GvHD after allogeneic hematopoietic cell transplantation, Bone Marrow Transplant, 51, 96, 10.1038/bmt.2015.205 Jordan, 2015, Prognostic significance of liver parameters at 1-year follow-up in children and adults undergoing myeloablative allogeneic stem cell transplantation, Bone Marrow Transplant, 50, 876, 10.1038/bmt.2015.54 Filipovich, 2005, National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease. I. Diagnosis and Staging Working Group report, Biol Blood Marrow Transplant, 11, 945, 10.1016/j.bbmt.2005.09.004 Strasser, 2000, Chronic graft-versus-host disease of the liver: presentation as an acute hepatitis, Hepatology, 32, 1265, 10.1053/jhep.2000.20067 Maximova, 2016, Safety and utility of percutaneous liver biopsy in hematopoietic stem cell transplant pediatric recipients: a retrospective study, BMC Cancer, 16, 590, 10.1186/s12885-016-2603-8 Maximova, 2017, Comparison of efficacy and safety of caspofungin versus micafungin in pediatric allogeneic stem cell transplant recipients: a retrospective analysis, Adv Ther, 34, 1, 10.1007/s12325-017-0534-7 Przepiorka, 1995, 1994 consensus conference on acute GVHD grading, Bone Marrow Transplant, 15, 825 Shulman, 2006, Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease. II. Pathology Working Group report, Biol Blood Marrow Transplant, 12, 31, 10.1016/j.bbmt.2005.10.023 Jagasia, 2015, National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease. I. The 2014 Diagnosis and Staging Working Group report, Biol Blood Marrow Transplant, 21, 389, 10.1016/j.bbmt.2014.12.001 Vigorito, 2009, Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD, Blood, 114, 702, 10.1182/blood-2009-03-208983 Duarte, 2005, Histologic features of the liver biopsy predict the clinical outcome for patients with graft-versus-host disease of the liver, Biol Blood Marrow Transplant, 11, 805, 10.1016/j.bbmt.2005.06.008 Bateman, 2010, Cytokeratin expression as an aid to diagnosis in medical liver biopsies, Histopathology, 56, 415, 10.1111/j.1365-2559.2009.03391.x Wolff, 2013, Current practice in diagnosis and treatment of acute graft-versus-host disease: results from a survey among German-Austrian-Swiss hematopoietic stem cell transplant centers, Biol Blood Marrow Transplant, 19, 767, 10.1016/j.bbmt.2013.01.018 Ma, 2004, Hepatic graft-versus-host disease after hematopoietic stem cell transplantation: clinico-pathological features and prognostic implication, Transplantation, 77, 1252, 10.1097/01.TP.0000120383.30088.A4 Demetris, 2016, Functional immune anatomy of the liver—as an allograft, Am J Transplant, 16, 1653, 10.1111/ajt.13749 McDonald, 2006, Advances in prevention and treatment of hepatic disorders following hematopoietic cell transplantation, Best Pract Res Clin Haematol, 19, 341, 10.1016/j.beha.2005.11.008 Bonkovsky, 2017, Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements, Hepatology, 65, 1267, 10.1002/hep.28967 List, 1993, Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia, J Clin Oncol, 11, 1652, 10.1200/JCO.1993.11.9.1652 Bhatia, 2007, Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study, Blood, 110, 3784, 10.1182/blood-2007-03-082933 Barshes, 2005, Liver transplantation for severe hepatic graft-versus-host disease: an analysis of aggregate survival data, Liver Transplant, 11, 525, 10.1002/lt.20389 Casotti, 2013, Vanishing bile duct syndrome in paediatric liver transplantation: impact of immunosuppressive treatment on biochemical and histological progression, J Pediatr Gastroenterol Nutr, 56, 141